NCT02239380 Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan Status COMPLETED Phase PHASE3
NCT02238717 Assessment of the Analgesic Effects of PF-06372865 in Healthy Volunteers Using Evoked Pain Endpoints Status COMPLETED Phase PHASE1
NCT02238496 Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas Status COMPLETED Phase PHASE1
NCT02237742 A Study To Understand How The Body Reacts To A Low Dose Of PF-06427878 When Given In A Vein To Healthy, Adult, Males Status COMPLETED Phase PHASE1
NCT02237729 A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07)) Status COMPLETED Phase PHASE1
NCT02231957 Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions Status COMPLETED Phase NA
NCT02228382 Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors Status TERMINATED Phase PHASE4
NCT02227550 Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy Status COMPLETED Phase PHASE4
NCT02226172 Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With Ruxolitinib Status TERMINATED Phase PHASE2
NCT02226003 Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017) Status COMPLETED Phase PHASE3
NCT02224664 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's Disease Status COMPLETED Phase PHASE1
NCT02224651 Study to Evaluate Safety and Tolerability of Single Ascending Doses of Multiple Formulations of PF-06650833 in Healthy Subjects Under Fasted and Fed Conditions Status COMPLETED Phase PHASE1
NCT02223819 Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy Status COMPLETED Phase PHASE2
NCT02222922 A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02222493 A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). Status COMPLETED Phase PHASE3
NCT02222441 Effect Of Modafinil And Pioglitazone On The Pharmacokinetics Of Palbociclib (PD-0332991) Status COMPLETED Phase PHASE1
NCT02219048 An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma Status TERMINATED Phase PHASE2
NCT02217813 A Bioequivalence Study Comparing Two Different Tafamidis Formulations Status COMPLETED Phase PHASE1
NCT02216097 A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress Disorder Status TERMINATED Phase PHASE2